EUDA EUDA Health Holdings Ltd
Services-Health Services · Nasdaq · SEC CIK 1847846 · Fiscal year ends 12/31
Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year
Growth
TTM revenue YoY70.0%
TTM net income YoY81.9%
TTM EPS YoY84.4%
Revenue 3-yr CAGR21.9%
Net income 3-yr CAGR—
Margins
Gross margin43.9%
Operating margin-36.3%
Net margin-40.7%
FCF margin-36.7%
EBITDA margin-33.5%
Returns
ROE—
ROA-162.4%
ROIC (approx.)—
Asset turnover4.00x
Leverage & solvency
Liabilities / assets348.6%
Debt / equity—
Current ratio0.18x
Interest coverage-10.84x
Cash quality & payout
Operating cash flow / net income0.88x
Accruals ratio-20.3%
Payout ratio—
Capex / revenue1.1%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2023Q2*2023-06-30 | 2023Q12023-03-31 | 2022Q12022-10-31 | 2022Q4*2022-07-31 | 2022Q32022-04-30 | 2022Q32022-03-31 | 2022Q22022-01-31 | 2022Q12021-10-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $104,276 | $1.70M | — | — | — | $2.67M | — | — |
| Cost of revenue | $64,184 | $1.30M | — | — | — | $1.40M | — | — |
| Gross profit | $40,092 | $403,598 | — | — | — | $1.27M | — | — |
| R&D expense | — | — | — | — | — | $2,946 | — | — |
| SG&A expense | $806,365 | $1.98M | — | — | — | $824,896 | — | — |
| Operating income | -$738,974 | -$1.98M | -$298,331 | -$1.23M | -$481,638 | $75,312 | -$225,636 | -$45,587 |
| Pretax income | -$4.78M | -$2.41M | — | — | — | $230,817 | — | — |
| Income tax | — | $985 | — | — | — | $5,823 | — | — |
| Net income | -$6.10M | -$2.41M | $201,012 | -$1.02M | -$472,989 | $222,585 | -$224,890 | -$45,587 |
| EBITDA | -$740,381 | -$1.97M | — | — | — | $82,262 | — | — |
| EPS (basic) | — | -0.12 | — | — | — | 0.02 | — | -0.02 |
| EPS (diluted) | — | -0.12 | — | — | — | 0.02 | — | -0.02 |
| Weighted avg. shares (diluted) | — | 20.19M | — | — | — | 9.25M | — | 1.88M |
| Balance sheet | ||||||||
| Cash & equivalents | — | $837,292 | $265,852 | $193,546 | $546,887 | — | $587,430 | $0 |
| Receivables | — | $1.59M | — | — | — | — | — | — |
| Current assets | — | $24.80M | $87.27M | $86.78M | $86.94M | — | $86.98M | — |
| PP&E, net | — | $27,892 | — | — | — | — | — | — |
| Total assets | — | $25.48M | $87.27M | $86.78M | $86.94M | — | $86.98M | $490,164 |
| Current liabilities | — | $31.33M | — | — | — | — | — | $506,628 |
| Total liabilities | — | $31.42M | $5.02M | $4.73M | $3.88M | — | $3.44M | $506,628 |
| Shareholders' equity | -$5.98M | -$5.95M | -$4.02M | -$3.72M | -$2.49M | $821,030 | -$2.01M | -$16,464 |
| Shares outstanding | — | 20.19M | 2.45M | 2.45M | 2.45M | — | 2.45M | 2.16M |
| Cash flow statement | ||||||||
| Operating cash flow | -$1.71M | -$469,908 | -$123,800 | -$353,341 | -$540,543 | -$252,196 | — | — |
| Investing cash flow | — | — | — | $0 | $0 | -$29,326 | — | — |
| Financing cash flow | $1.19M | $525,328 | $196,106 | $0 | $500,000 | $331,439 | — | — |
| Depreciation & amortization | -$1,407 | $3,981 | — | — | — | $6,950 | — | — |
Free plan shows the latest 8 periods; Pro shows all 10 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.